Aripiprazole treatment of Asperger's syndrome in the acute psychiatric setting: Case report

Neuropsychiatric Disease and Treatment

Volumn 3, Issue 1, 2007, Pages 173-176

  Dratcu, Luiz ^a   McKay, Gavin ^a   Singaravelu, Vinod ^a   Krishnamurthy, Venkat ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Aripiprazole; Asperger's syndrome; Atypical antipsychotics; Autism spectrum disorders; Dopamine; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; DOPAMINE 2 RECEPTOR; FLUOXETINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; ASPERGER SYNDROME; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DRUG MECHANISM; DRUG TOLERABILITY; FAMILY HISTORY; HOSPITAL ADMISSION; HUMAN; LONG TERM CARE; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; NEUROBIOLOGY; PATIENT ATTITUDE; PATIENT REFERRAL; PSYCHOTHERAPY; SCHIZOPHRENIA; UNSPECIFIED SIDE EFFECT;

EID: 34249053830     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/nedt.2007.3.1.173     Document Type: Article

References (21)

1. [APA] American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental disorders, 4th ed - Text Revision (DSM IV - TR); Washington DC: American Psychiatric Press, Inc.
2. Anderson LT, Campbell M, Grega DM, et al. 1984. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry, 141:1195-202.
3. Baron-Cohen S, Wheelwright S, Skinner R, et al. 2001. The Autism spectrum Quotient (AQ): Evidence from Asperger syndrome/high functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord, 31:5-17.
4. Berthier ML, Kulisevsky J, Asenjo B, et al. 2003. Comorbid Asperger and Tourette syndromes with localized mesencephalic, infrathalamic, thalamic, and striatal damage. Dev Med Child Neurol, 45:207-12.
5. Bostic JQ, King BH. 2005. Autism spectrum disorders: emerging pharmacotherapy. Expert Opin Emerg Drugs, 10:521-36.
6. Bowles TM, Levin GM. 2003. Aripiprazole: a new atypical antipsychotic drug. Ann Pharmacother, 37:687-94.
7. Brambilla P, Hardan AY, di Nemi SU, et al. 2004. The functional neuroanatomy of autism. Funct Neurol, 19:9-17.
8. British National Formulary. 2005. British Medical Association and Royal Pharmaceutical Society of Great Britain (eds). London.
9. Dratcu L, Olowu P, Hawramy M, et al. 2006. Aripiprazole in the acute treatment of male patients with schizophrenia: effectiveness, acceptability, and risks in the inner-city hospital setting. Neuropsychiatr Div Treat, 2:191-7.
10. Frith U. 2004. Emanuel Miller lecture: confusions and controversies about Asperger syndrome. J Child Psychol Psychiatry, 45:672-86.
11. Gillberg C, Billstedt E. 2000. Autism and Asperger syndrome: coexistence with other clinical disorders. Acta Psychiatr Scand, 102:321-30.
12. Lauritsen MB, Pedersen CB, Mortensen PB. 2004. The incidence and prevalence of pervasive developmental disorders: a Danish population-based study. Psychol Med, 34:1339-46.
13. McAlonan GM, Daly E, Kumari V, et al. 2002. Brain anatomy and sensorimotor gating in Aperger's syndrome. Brain, 125:1594-606.
14. McDougle CJ, Holmes JP, Carlson DC, et al 1998. A bouble-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry, 55:633-41.
15. Nieminen-von Wendt TS, Metsahonkala L, Kulomaki TA, et al. 2004. Increased presynaptic dopamine function in Asperger syndrome. Neuroreport, 15:757-60.
16. Raja M, Azzoni A. 2001. Asperger's disorder in the emergency psychiatric setting. General Hosp Psychiatry, 23:285-93.
17. Rausch JL, Sirota EL, Londino DL et al. 2005. Open-label risperidone for Asperger's disorder: negative symptom spectrum response. J Clin Psychiatry, 66:1592-7.
18. Staller JA. 2003. Aripiprazole ia an adult with Asperger disorder. Ann Pharmacother, 37:1628-31.
19. Tani P, Lindberg N, Appelberg B, et al. 2006. Clinical neurological abnormalities in young adults with Asperger syndrome. Psychiatry Clin Neurosci, 60:253-55.
20. Welchew DE, Aswhin C, Berkouk K, et al. 2005. Functional disconnectivity of the medial temporal lobe in Asperger's syndrome. Biol Psychiatry, 57:991-8.
21. [WHO] World Health Organization. 1992. ICD-10: The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.